Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

71 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Analysis of Inactivation of SARS-CoV-2 by Specimen Transport Media, Nucleic Acid Extraction Reagents, Detergents, and Fixatives.
Welch SR, Davies KA, Buczkowski H, Hettiarachchi N, Green N, Arnold U, Jones M, Hannah MJ, Evans R, Burton C, Burton JE, Guiver M, Cane PA, Woodford N, Bruce CB, Roberts ADG, Killip MJ. Welch SR, et al. J Clin Microbiol. 2020 Oct 21;58(11):e01713-20. doi: 10.1128/JCM.01713-20. Print 2020 Oct 21. J Clin Microbiol. 2020. PMID: 32839250 Free PMC article.
Detection of SARS-CoV-2 within the healthcare environment: a multi-centre study conducted during the first wave of the COVID-19 outbreak in England.
Moore G, Rickard H, Stevenson D, Aranega-Bou P, Pitman J, Crook A, Davies K, Spencer A, Burton C, Easterbrook L, Love HE, Summers S, Welch SR, Wand N, Thompson KA, Pottage T, Richards KS, Dunning J, Bennett A. Moore G, et al. Among authors: welch sr. J Hosp Infect. 2021 Feb;108:189-196. doi: 10.1016/j.jhin.2020.11.024. Epub 2020 Nov 28. J Hosp Infect. 2021. PMID: 33259882 Free PMC article.
Virucidal efficacy of guanidine-free inactivants and rapid test buffers against SARS-CoV-2.
Davies K, Arnold U, Buczkowski H, Burton C, Welch SR, Green N, Strachan R, Beetar-King T, Spencer P, Hettiarachchi N, Hannah MJ, Jones M, Cane PA, Bruce CB, Woodford N, Roberts ADG, Killip MJ. Davies K, et al. Among authors: welch sr. Sci Rep. 2021 Dec 3;11(1):23379. doi: 10.1038/s41598-021-02942-4. Sci Rep. 2021. PMID: 34862448 Free PMC article.
Mouse models of Ebola virus tolerance and lethality: characterization of CD-1 mice infected with wild-type, guinea pig-adapted, or mouse-adapted virus.
Spengler JR, Welch SR, Ritter JM, Harmon JR, Coleman-McCray JD, Genzer SC, Seixas JN, Scholte FEM, Davies KA, Bradfute SB, Montgomery JM, Spiropoulou CF. Spengler JR, et al. Among authors: welch sr. Antiviral Res. 2023 Feb;210:105496. doi: 10.1016/j.antiviral.2022.105496. Epub 2022 Dec 22. Antiviral Res. 2023. PMID: 36567020
Single-dose mucosal replicon-particle vaccine protects against lethal Nipah virus infection up to 3 days after vaccination.
Welch SR, Spengler JR, Genzer SC, Coleman-McCray JD, Harmon JR, Sorvillo TE, Scholte FEM, Rodriguez SE, O'Neal TJ, Ritter JM, Ficarra G, Davies KA, Kainulainen MH, Karaaslan E, Bergeron É, Goldsmith CS, Lo MK, Nichol ST, Montgomery JM, Spiropoulou CF. Welch SR, et al. Sci Adv. 2023 Aug 4;9(31):eadh4057. doi: 10.1126/sciadv.adh4057. Epub 2023 Aug 4. Sci Adv. 2023. PMID: 37540755 Free PMC article.
71 results